ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Gavel Changes Hands At NCAB, Korn advises New Members On Role

February 8, 1991

In Congress: Bill Introduced In House On Payment for Patient Care Costs In Trials; Senate Defeats Bill To Cut Teen Smoking

May 23, 1997

Members of Congress say that won’t work.

September 30, 2005

NCI Remains Exception To NIH Authority Over Scientific Counselors

January 27, 1995

In Brief: Hellman Will Leave Harvard To Become Physician In Chief At Memorial. James Awards Announced

April 22, 1983

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993